Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Michlmayr

Showing results (21-30 of 71) with videos related to

Pageof 8
Sort By:
Klinische Wochenschrift|August 1, 1976
Immunological characterization of lymphoproliferative disorders by membrane markersH Huber, G Michlmayr, C Huber, et al.
Immunobiology|October 1, 1982
Normal suppressor-cell activity in systemic lupus erythematosus. A study on 26 casesC Gattringer, H Huber, G Michlmayr, et al.
European Journal of Cancer|August 1, 1974
Redistribution of immunoglobulin determinants on human lymphocytes in lymphoproliferative disordersC Huber, G Michlmayr, H Braunsteiner, et al.
Acta Haematologica|January 1, 1975
Insoluble PHA- A B-cell mitogen in man?G Michlmayr, C Huber, H Braunsteiner, et al.
Acta Medica Austriaca|January 1, 1979
[A method for the detection of suppressor lymphocytes and its clinical use]C Gattringer, G Michlmayr, H Huber, et al.
Schweizerische Medizinische Wochenschrift|June 3, 1978
[Humoral and cellular immune mechanisms in venous occlusive lung diseases]W Stühlinger, G Michlmayr, G Mikuz, et al.
Wiener Klinische Wochenschrift|March 20, 1981
[Encouraging results with cytostatic therapy in metastasizing breast cancer (author's transl)]G Michlmayr, H Kratzer, H Denz, et al.
Deutsche Medizinische Wochenschrift (1946)|May 18, 1973
[Experiences in therapy of aplastic anemias using oxymetholone]G Michlmayr, C Huber, G Judmaier, et al.
Clinical and Experimental Immunology|April 1, 1976
Antibodies for T lymphocytes in systemic lupus erythematosusG Michlmayr, C Pathouli, C Huber, et al.
Blut|January 1, 1971
[Reduced survival time of DF 32 P-labeled granulocytes following isolation with dextran or ammonium chloride]H Bolland, H Pfisterer, W Ruppelt, et al.
Pageof 8

Showing results (21-30 of 71) with videos related to

Sort By:
Pageof 8
Klinische Wochenschrift|August 1, 1976
Immunological characterization of lymphoproliferative disorders by membrane markersH Huber, G Michlmayr, C Huber, et al.
Immunobiology|October 1, 1982
Normal suppressor-cell activity in systemic lupus erythematosus. A study on 26 casesC Gattringer, H Huber, G Michlmayr, et al.
European Journal of Cancer|August 1, 1974
Redistribution of immunoglobulin determinants on human lymphocytes in lymphoproliferative disordersC Huber, G Michlmayr, H Braunsteiner, et al.
Acta Haematologica|January 1, 1975
Insoluble PHA- A B-cell mitogen in man?G Michlmayr, C Huber, H Braunsteiner, et al.
Acta Medica Austriaca|January 1, 1979
[A method for the detection of suppressor lymphocytes and its clinical use]C Gattringer, G Michlmayr, H Huber, et al.
Schweizerische Medizinische Wochenschrift|June 3, 1978
[Humoral and cellular immune mechanisms in venous occlusive lung diseases]W Stühlinger, G Michlmayr, G Mikuz, et al.
Wiener Klinische Wochenschrift|March 20, 1981
[Encouraging results with cytostatic therapy in metastasizing breast cancer (author's transl)]G Michlmayr, H Kratzer, H Denz, et al.
Deutsche Medizinische Wochenschrift (1946)|May 18, 1973
[Experiences in therapy of aplastic anemias using oxymetholone]G Michlmayr, C Huber, G Judmaier, et al.
Clinical and Experimental Immunology|April 1, 1976
Antibodies for T lymphocytes in systemic lupus erythematosusG Michlmayr, C Pathouli, C Huber, et al.
Blut|January 1, 1971
[Reduced survival time of DF 32 P-labeled granulocytes following isolation with dextran or ammonium chloride]H Bolland, H Pfisterer, W Ruppelt, et al.
Pageof 8